Status:
COMPLETED
Hydrosalpinx Management Before Intracytoplasmic Sperm Injection
Lead Sponsor:
Cairo University
Conditions:
Hydrosalpinx
Eligibility:
FEMALE
20-35 years
Brief Summary
ICSI pregnancy outcomes following hysteroscopic tubal electrocoagulation versus laparoscopic tubal disconnection for patients with hydrosalpinges
Detailed Description
Tubal factor of infertility resulting from various forms of tuboperitoneal damage remains an extremely common cause of female infertility, accounting for more than 35% of all cases of female infertili...
Eligibility Criteria
Inclusion
- Age from 20 to 35 years
- Primary or secondary infertility.
- Diagnosis of hydrosalpinx; diagnosed by HSG and TV U/S.
- Necessity of an IVF procedure.
Exclusion
- Patients with uterine factor infertility.
- Medical or surgical conditions contraindicating pregnancy.
- Poor responders according to reference criteria.
- Cases of polycystic ovary disease.
Key Trial Info
Start Date :
March 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2018
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03854292
Start Date
March 1 2017
End Date
May 31 2018
Last Update
July 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Cairo, Egypt